SEC Form 3 · accession 0001209191-15-056409
Seres Therapeutics, Inc. · MCRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Barton Hutt
Director
Period of report
Jun 25, 2015
Accepted (ET)
Jun 25, 2015 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.48 | holding | — | — | — | — | Nov 6, 2023 | Common Stock | 50,000 | — | D |
Explanation of responses
- F1The option vested as to 25% of the shares on May 17, 2014. The remainder of the shares vested or will vest in 12 equal quarterly installments thereafter.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney